Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M HINES

Showing results (251-260 of 424) with videos related to

Pageof 43
Sort By:
Msphere|December 16, 2017
Characterization of the Mechanisms of Daptomycin Resistance among Gram-Positive Bacterial Pathogens by Multidimensional LipidomicsKelly M Hines, Adam Waalkes, Kelsi Penewit, et al.
Genome Biology and Evolution|September 29, 2017
Queens and Workers Contribute Differently to Adaptive Evolution in Bumble Bees and Honey BeesBrock A Harpur, Alivia Dey, Jennifer R Albert, et al.
Current Medical Research and Opinion|August 22, 2022
Risk of stroke/systemic embolism, major bleeding, and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran, or rivaroxaban compared with warfarin in the United States medicare population: updated analysisAlpesh Amin, Allison Keshishian, Dionne M Hines, et al.
Rheumatology and Therapy|October 18, 2016
Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective AnalysisRobert Morlock, Pierre Chevalier, Laura Horne, et al.
Infection Control and Hospital Epidemiology|March 19, 2021
Mitigating staff shortages: Risk of permitting healthcare workers to return to work after coronavirus disease 2019 (COVID-19) exposureCherie Faith Lopez Monsalud, Mary Frazier Greene Lind, Carolyn M Hines, et al.
Scientific Reports|January 21, 2018
Prevention of Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz SyndromeSteven J Fliesler, Neal S Peachey, Josi Herron, et al.
Advances in Therapy|May 28, 2016
Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective AnalysisFredrik Nyberg, Laura Horne, Robert Morlock, et al.
Scientific Reports|March 8, 2018
Author Correction: Prevention of Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz SyndromeSteven J Fliesler, Neal S Peachey, Josi Herron, et al.
Current Medical Research and Opinion|February 9, 2024
Effectiveness and safety of anticoagulants among patients with venous thromboembolism and active cancer who also had prior bleed or prior renal diseaseAlexander T Cohen, Virginia Noxon, Amol D Dhamane, et al.
Journal of Medical Economics|January 17, 2025
Decision model to evaluate the cost of clinical events associated with switching from apixaban to rivaroxaban among patients with non-valvular atrial fibrillation in the United States and GermanyRupesh Subash, Cecilia Duan, Anshul Shah, et al.
Pageof 43

Showing results (251-260 of 424) with videos related to

Sort By:
Pageof 43
Msphere|December 16, 2017
Characterization of the Mechanisms of Daptomycin Resistance among Gram-Positive Bacterial Pathogens by Multidimensional LipidomicsKelly M Hines, Adam Waalkes, Kelsi Penewit, et al.
Genome Biology and Evolution|September 29, 2017
Queens and Workers Contribute Differently to Adaptive Evolution in Bumble Bees and Honey BeesBrock A Harpur, Alivia Dey, Jennifer R Albert, et al.
Current Medical Research and Opinion|August 22, 2022
Risk of stroke/systemic embolism, major bleeding, and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran, or rivaroxaban compared with warfarin in the United States medicare population: updated analysisAlpesh Amin, Allison Keshishian, Dionne M Hines, et al.
Rheumatology and Therapy|October 18, 2016
Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective AnalysisRobert Morlock, Pierre Chevalier, Laura Horne, et al.
Infection Control and Hospital Epidemiology|March 19, 2021
Mitigating staff shortages: Risk of permitting healthcare workers to return to work after coronavirus disease 2019 (COVID-19) exposureCherie Faith Lopez Monsalud, Mary Frazier Greene Lind, Carolyn M Hines, et al.
Scientific Reports|January 21, 2018
Prevention of Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz SyndromeSteven J Fliesler, Neal S Peachey, Josi Herron, et al.
Advances in Therapy|May 28, 2016
Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective AnalysisFredrik Nyberg, Laura Horne, Robert Morlock, et al.
Scientific Reports|March 8, 2018
Author Correction: Prevention of Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz SyndromeSteven J Fliesler, Neal S Peachey, Josi Herron, et al.
Current Medical Research and Opinion|February 9, 2024
Effectiveness and safety of anticoagulants among patients with venous thromboembolism and active cancer who also had prior bleed or prior renal diseaseAlexander T Cohen, Virginia Noxon, Amol D Dhamane, et al.
Journal of Medical Economics|January 17, 2025
Decision model to evaluate the cost of clinical events associated with switching from apixaban to rivaroxaban among patients with non-valvular atrial fibrillation in the United States and GermanyRupesh Subash, Cecilia Duan, Anshul Shah, et al.
Pageof 43